Top Fundamental Stock ‘Buy’ Calls for Bajaj Auto, Samvardhana Motherson, Alkem Labs and More: Dalal Street benchmarks appear to be stuck in ranges once again, with the Nifty 50 index remaining almost 1,500 points below its late-September peak. As the earnings season draws to a close, the focus shifts to macroeconomic data, institutional fund flows and global cues. Here’s what brokerages such as Jefferies, Citi and Goldman Sachs make of buzzing stocks in the market now.
Bajaj Auto Share Price Target | How brokerages view Nifty Auto stock
Jefferies has maintained a ‘buy’ rating on Bajaj Auto while raising its raget price to Rs 8,000 from Rs 7,750 per share.
According to the brokerage, the auto maker staged a decent Q4 performance driven by an improvement in its average selling price.
Jefferies continues to be positive on Bajaj Auto citing a positive growth outlook on both two-wheeler sales in domestic as well as foreign markets.
However, the brokerage is concerned about a dip in Bajaj Auto’s market share in the domestic motorcycle market.
| Brokerage | Rating | Target price |
| Jefferies | Buy | Raised to Rs 8,000 from Rs 7,750 |
| Goldman Sachs | Buy | Raised to Rs 9,600 from Rs 9,300 |
Goldman Sachs has maintained a ‘buy’ rating on Bajaj Auto and raised its target price to Rs 9,600 from Rs 9,300 per share.
Goldman Sachs maintains ‘buy’ on Ola Electric
Goldman Sachs has continued with its ‘buy’ rating on Ola Electric Mobility but reduced its target price for the stock to Rs 70 from Rs 75.
The brokerage has revised downwards its revenue estimates for Ola Electric by 19 per cent, 12 per cent and 11 per cent for FY26, FY27 and FY28 respectively.
According to Goldman Sachs, the electric vehicle maker’s EBITDA breakeven is now pushed out to the second quarter of the current financial year.
Samvardhana Motherson Stock Target | How brokerages view the largecap auto ancillary stock
Jefferies has retained its ‘buy’ rating and raised its target price by Rs 15 to Rs 130 apiece for Samaradhana Motherson shares.
Nomura has a ‘buy’ call on the stock with a revised target of Rs 170, instead of the earlier Rs 155.
Alkem Labs Stock Target | How brokerages view the pharma scrip
Nomura has continued its ‘buy’ rating for the Alkem Labs stock.
The brokerage has kept its target for the largecap pharmaceutical stock at Rs 5,430.
Anurag Dhole is a seasoned journalist and content writer with a passion for delivering timely, accurate, and engaging stories. With over 8 years of experience in digital media, she covers a wide range of topics—from breaking news and politics to business insights and cultural trends. Jane's writing style blends clarity with depth, aiming to inform and inspire readers in a fast-paced media landscape. When she’s not chasing stories, she’s likely reading investigative features or exploring local cafés for her next writing spot.
- ANURAG DHOLEhttps://indiatadkha.com/author/bitlancetechhubgmail-com/
- ANURAG DHOLEhttps://indiatadkha.com/author/bitlancetechhubgmail-com/
- ANURAG DHOLEhttps://indiatadkha.com/author/bitlancetechhubgmail-com/
- ANURAG DHOLEhttps://indiatadkha.com/author/bitlancetechhubgmail-com/
